In what may be an important piece of information for many men with prostate cancer, the U.S. Food and Drug Administration yesterday approved the first generic form of the erectile dysfunction drug sildenafil or Viagra.
The generic formulation is to be marketed initially by Teva, who will launch it on December 11, 2017, so don’t rush out to your pharmacy tomorrow hoping to be able to get it on the cheap!
The other thing to be aware of is that, as of December 11, 2017, Teva will have 6 months of exclusivity as the only provider of a generic formulation here in the US, so the price won’t drop that much until July 11, 2018. After that date, any generic manufacturer will be able to make and sell generic sildenafil, so we can expect the price to drop like a stone thereafter.
Filed under: Living with Prostate Cancer, Management | Tagged: generic, sildenafil, Viagra |
THE "NEW" PROSTATE CANCER INFOLINK 
Until then, I guess the Canadians/Indians/Indonesians will still be getting my business.
I had my right testis removed about 20 years ago. Now was told that I have prostate cancer, but my only testis hurts. Would that be the cause of the prostate cancer?
Dear Joe:
You’d really need to talk to your doctors about that, but I don’t know of any reason why that would be the case.